Exicure, Inc. Files 8-K
Ticker: XCUR · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
Related Tickers: XCUR
TL;DR
EXICURE (XCUR) filed an 8-K on Nov 20, 2024. Standard disclosure.
AI Summary
Exicure, Inc. filed an 8-K on November 20, 2024, reporting other events. The company, previously known as Max-1 Acquisition Corp, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Chicago, IL.
Why It Matters
This filing indicates a routine update or event disclosure by Exicure, Inc. to the SEC, which may contain information relevant to investors.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for 'Other Events' and does not appear to contain material non-public information that would immediately impact the stock price.
Key Numbers
- 001-39011 — SEC File Number (Identifies the company's filing history with the SEC.)
- 81-5333008 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- EXICURE, INC. (company) — Registrant
- Max-1 Acquisition Corp (company) — Former company name
- November 20, 2024 (date) — Date of earliest event reported
- Chicago, IL (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific 'Other Events' are being reported by Exicure, Inc. in this 8-K filing?
The filing itself is the 'Other Event' being reported, indicating a disclosure of information under Item 8.01 of Form 8-K, but the specific details of the event are not elaborated in the provided header information.
When was Exicure, Inc. previously known as Max-1 Acquisition Corp?
The date of the name change from Max-1 Acquisition Corp to Exicure, Inc. was February 21, 2017.
What is Exicure, Inc.'s Standard Industrial Classification (SIC) code?
Exicure, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where are Exicure, Inc.'s principal executive offices located?
Exicure, Inc.'s principal executive offices are located at 2430 N. Halsted St., Chicago, IL 60614.
What is the SEC file number for Exicure, Inc.?
The SEC file number for Exicure, Inc. is 001-39011.
Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-11-20 16:25:27
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20241120.htm (8-K) — 22KB
- 0001698530-24-000119.txt ( ) — 141KB
- xcur-20241120.xsd (EX-101.SCH) — 2KB
- xcur-20241120_lab.xml (EX-101.LAB) — 21KB
- xcur-20241120_pre.xml (EX-101.PRE) — 12KB
- xcur-20241120_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events On November 20, 2024, the Nasdaq Hearings Panel granted another extension to continue the Company's listing subject to the Company evidencing compliance with all applicable criteria for continued listing by December 17, 2024. The Company continues to work to satisfy the applicable requirements, including through the recently announced financing transactions with HiTron Systems Inc. However, the Company will not be entitled to any further extensions from the Panel and cannot provide any assurance as to whether the Company can adequately demonstrate to the Panel's satisfaction by the deadline that it has regained, and will be able to maintain, compliance with the continued listing standards in order to avoid delisting.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 20, 2024 EXICURE, INC. By: /s/ Paul Kang Paul Kang Chief Executive Officer